Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor
about
Ezetimibe therapy: mechanism of action and clinical updateThe pivotal role of cholesterol absorption inhibitors in the management of dyslipidemiaNovel therapies for the prevention of strokeThe target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)Effect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietIndices of cholesterol metabolism and relative responsiveness to ezetimibe and simvastatin.Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.Cholesterol absorption inhibitors as a therapeutic option for hypercholesterolaemia.Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?Efficacy and tolerability of ezetimibe 10 mg/day coadministered with statins in patients with primary hypercholesterolemia who do not achieve target LDL-C while on statin monotherapy: A Canadian, multicentre, prospective study--the Ezetrol Add-On StLipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies.Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition.Roles of the gut in the metabolic syndrome: an overview.Fungal biotransformation of ezetimibe.Marketed drugs used for the management of hypercholesterolemia as anticancer armament.Safety of coadministration of ezetimibe and statins in patients with hypercholesterolaemia: a meta-analysis.Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects.Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.Role of enterohepatic recirculation in drug disposition: cooperation and complications.Pharmacokinetics, pharmacodynamics and clinical efficacy of non-statin treatments for hypercholesterolemia.Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjects.Ezetimibe: one step beyond in the battle against atherosclerosis
P2860
Q24630302-8CB65412-87F1-455D-83E0-CCF28222BB81Q24805607-92A2EBDA-BDF5-437F-A53C-D7466266FA6CQ28210724-2846E6C1-B454-4926-83CE-3E957D6A2A20Q28573173-AA58771F-4A61-40EE-A6A3-CEDDE611EFF2Q33804734-14942A7B-08D0-4711-B842-80334D4BA5AAQ34812315-55E88419-6DF5-48E2-B7CF-11EA5A614F34Q36596847-6114A5BF-AE14-42E5-8F95-E66C64CF72C5Q36623056-7FD517C8-9E8E-467B-81F3-D73ACCB33738Q36847314-7E63248E-BCEF-4689-99D2-54128AD9EFD4Q36940565-8A85DB15-06C6-4EAB-92A0-E0860CDA0936Q37993779-02E7CA18-0A01-4EEA-9B22-1C56DDCC5144Q38195808-65756610-1894-470F-AEF1-14804E083539Q38780926-3B5A8A46-0CCA-4BB1-BA3A-DFE819FAF872Q40736415-8E29CEAF-BDEF-42B9-8C48-F36CAE89E676Q41080847-74D1AC7D-AB60-44C8-A4F8-5E601223E745Q41490656-FAF0E043-3AC2-4045-AC4F-34B206E4E92DQ41582149-E3549B98-1F87-4118-B2CD-337897C4F25CQ42627615-BBFD6900-B519-48E1-806F-44242AEBA074Q43196457-2A493ADD-4080-4947-8515-F7DA300C6148Q46578287-CA012811-C6B8-4977-9721-04B08E123C63Q47303571-75C7A1D9-FEE1-4853-93B8-514A1EA4AADDQ47785743-A6DD0DAB-4D07-4666-9DA6-97A34674DA12Q51299977-6EA33F38-60D8-469C-A76C-95E41E73F6DBQ57761479-590C4619-AC28-4156-BF8E-66A5F2D42598
P2860
Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@ast
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@en
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@nl
type
label
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@ast
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@en
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@nl
prefLabel
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@ast
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@en
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@nl
P1476
Pharmacology and therapeutics ...... olesterol-absorption inhibitor
@en
P2093
Judy W M Cheng
LilyAnn Jeu
P304
P356
10.1016/S0149-2918(03)80281-3
P407
P577
2003-09-01T00:00:00Z